The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.

Bristol Myers Squibb was among the investors in a series B round announced alongside a collaboration with the small molecule drug developer.

Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.

Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.

BMW and Ralph Lauren contributed to an $85m round for sustainable materials provider Natural Fiber Welding while Credit Saison invested $80m in virtual credit card service Julo.

Decentralised finance technology developer BloXroute raised $70m in a round led by SoftBank Vision Fund 2 while Ackermans & van Haaren helped digital health technology developer Medikabazaar score a $700m valuation.

Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

Prologis Ventures has returned to back the Associated Press, Samsung Next and Workday Ventures-backed business data software developer’s latest round, hiking its funding to over $132m in total.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.